<DOC>
	<DOCNO>NCT00950495</DOCNO>
	<brief_summary>The aim study compare effect mandibular advancement device ( MAD ) nasal continuous positive airway pressure ( nCPAP ) intra-oral placebo device obstructive sleep apnea ( OSA ) patient . The hypothesis study MAD therapy nCPAP therapy similar , well treatment effect placebo therapy OSA . The study perform accord CONSORT ( consolidated standard report trial ) statement ( Altman et al. , 2001 ) , employ parallel-group , randomize , placebo-controlled trial design .</brief_summary>
	<brief_title>Oral Appliance Therapy Obstructive Sleep Apnea</brief_title>
	<detailed_description>Setting participant : Eligible OSA patient , live great Amsterdam area , refer Slotervaart Medical Center family physician . All patient underwent thorough medical examination , include full polysomnographic ( PSG ) recording , department Neurology , Pulmonary Medicine , ENT , well thorough dental examination Department Oral Kinesiology ACTA . OSA patient invited participation study fulfil inclusion criterion exclusion criterion . Randomisation allocation : After write informed consent obtain , patient randomly allocate one three therapy group ( MAD , nCPAP , placebo ; see ) . To ensure group approx . size , block randomisation use . Block size 6 , 12 , 18 ; size randomly vary . The allocation sequence automatically generate subsequently conceal independent co-worker , keep paper copy lockable drawer . Sealed opaque envelope use conceal allocation principal investigator . Interventions blind : Three form therapy intervention use parallel-group study . First , individually fabricate MAD adjustable protrusive mandibular position constant vertical dimension use . Second , nCPAP REMstar Pro system use ( Respironics , Herrsching , Germany ) . Third , thin ( &lt; 1 mm ) , hard acrylic-resin palatal splint partial palatal coverage use placebo . Patients blind nature assign therapy ( placebo active ) . After evaluate therapy , patient ask opinion receive active placebo treatment . Blinding analyst ascertain assign code data set analyze set random block . Procedure : From patient , two full polysomnographic ( PSG ) recording obtain sleep laboratory Slotervaart Medical Center , use Siesta hardware Pro-Fusion software ( Compumedics , Abbotsford , Australia ) : one therapy assignment ( baseline PSG ) one 6 ± 2 month ( mean ± SD ) treatment ( therapy evaluation PSG ) . For MAD nCPAP group , third fourth PSG recording therapy evaluation perform 6 month one year first therapy evaluation ( long-term follow-up ) . The primary secondary outcome measure obtain baseline therapy evaluation . The MAD nCPAP titrate start treatment . The titration nCPAP perform third sleep laboratory examination . The pressure increase incremental step 1 cm H2O/h , respiratory disturbance respiration-related arousal reduce ≤ 5/h , snore minimize . For titration MAD , four ambulatory PSG recording obtain regular interval , use Monet hardware Rembrandt Software ( Medcare Automation B.V. , Amsterdam , The Netherlands ) . The effective protrusion position MAD ( i.e. , mandibular position yield low AHI value ) choose among four randomly offer position ( viz. , 0 % , 25 % , 50 % , 75 % maximum protrusion ) . For placebo group , study procedure make equally intense MAD group make four ambulatory PSG recording regular interval well .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>age &gt; 18 year apneahypopnea index ( AHI ) 5 45 event per hour evidence respiratory/ sleep disorder obstructive sleep apnea body mass index ( BMI ) &gt; 40 medication usage could influence respiration sleep periodic limb movement disorder previous treatment CPAP MAD reversible morphological upper airway abnormality ( e.g. , enlarge tonsil ) temporomandibular disorder ( base functional examination masticatory system ) untreated periodontal problem dental pain lack retention possibility mandibular advancement device placebo appliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Parallel design</keyword>
	<keyword>Oral appliance</keyword>
	<keyword>Mandibular advancement device</keyword>
	<keyword>Continuous positive airway pressure</keyword>
	<keyword>Placebo</keyword>
	<keyword>Therapy</keyword>
	<keyword>Side-effects</keyword>
	<keyword>Compliance</keyword>
</DOC>